The risk or severity of adverse effects can be increased when dyclonine is combined with amisulpride.


The risk or severity of adverse effects can be increased when Tolcapone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when sulpiride is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with triamterene.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with loteprednol.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Perospirone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when Olmesartan is combined with atenolol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when cilazapril is combined with nabumetone.


The risk or severity of adverse effects can be increased when irbesartan is combined with enalapril.


The risk or severity of adverse effects can be increased when Artesunate is combined with dapsone.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with nadolol.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with diflorasone.


The risk or severity of adverse effects can be increased when thiamylal is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Regorafenib.


The risk or severity of adverse effects can be increased when zotepine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when zotepine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with betaxolol.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when secobarbital is combined with efavirenz.


The risk or severity of adverse effects can be increased when Arotinolol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when secobarbital is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when haloperidol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nicardipine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when secobarbital is combined with clorazepate.


The risk or severity of adverse effects can be increased when methysergide is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when lidocaine is combined with sulpiride.


The risk or severity of adverse effects can be increased when tizanidine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when nimesulide is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when methylphenidate is combined with protriptyline.


The risk or severity of adverse effects can be increased when lidocaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ramipril is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when temazepam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when tetracaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Normethadone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Butethal.


The risk or severity of adverse effects can be increased when dantrolene is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when dantrolene is combined with flunarizine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when diflunisal is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when sevoflurane is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with amcinonide.


The risk or severity of adverse effects can be increased when topiramate is combined with ethotoin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with methazolamide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Eplerenone.


The risk or severity of adverse effects can be increased when ramipril is combined with doxazosin.


The risk or severity of adverse effects can be increased when flurazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when Halazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with lithium ion.


The risk or severity of adverse effects can be increased when bepridil is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when chloroquine is combined with haloperidol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with methazolamide.


The risk or severity of adverse effects can be increased when tenoxicam is combined with flumethasone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with methazolamide.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with nicardipine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when ramipril is combined with labetalol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with maprotiline.


The risk or severity of adverse effects can be increased when morniflumate is combined with tolmetin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with meperidine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with timolol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with quazepam.


The risk or severity of adverse effects can be increased when spironolactone is combined with propranolol.


The risk or severity of adverse effects can be increased when miconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when nitrazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when gabapentin is combined with amisulpride.


The risk or severity of adverse effects can be increased when clidinium is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when tolterodine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when oxprenolol is combined with papaverine.


The risk or severity of adverse effects can be increased when loxapine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when docetaxel is combined with prednisone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with clomipramine.


The risk or severity of adverse effects can be increased when butabarbital is combined with amoxapine.


The risk or severity of adverse effects can be increased when butabarbital is combined with nortriptyline.


The risk or severity of adverse effects can be increased when bromocriptine is combined with clindamycin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with captopril.


The risk or severity of adverse effects can be increased when procaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when procaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when procaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when temazepam is combined with butabarbital.


The risk or severity of adverse effects can be increased when clorazepate is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with flunisolide.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with pirenzepine.


The risk or severity of adverse effects can be increased when diazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when cilazapril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Salsalate is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when salicylamide is combined with DESONIDE.


The risk or severity of adverse effects can be increased when ethosuximide is combined with trimipramine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when moclobemide is combined with triflupromazine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with floctafenine.


The risk or severity of adverse effects can be increased when ipratropium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when loxapine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when pergolide is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when buspirone is combined with Normethadone.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Butethal.


The risk or severity of adverse effects can be increased when minocycline is combined with Acitretin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with amobarbital.


The risk or severity of adverse effects can be increased when pergolide is combined with Caspofungin.


The risk or severity of adverse effects can be increased when lidocaine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when glutethimide is combined with carisoprodol.


The risk or severity of adverse effects can be increased when bromazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when mesalamine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when amiodarone is combined with Phenelzine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Tramadol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with papaverine.


The risk or severity of adverse effects can be increased when butorphanol is combined with zotepine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with 5-Fluorouracil.


The risk or severity of adverse effects can be increased when amifostine is combined with amiodarone.


The risk or severity of adverse effects can be increased when buspirone is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with scopolamine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when clomipramine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when fenbufen is combined with triamcinolone.


The risk or severity of adverse effects can be increased when buspirone is combined with Melatonin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with felodipine.


The risk or severity of adverse effects can be increased when triazolam is combined with amisulpride.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with irbesartan.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when labetalol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Eplerenone is combined with terazosin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when glutethimide is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when reserpine is combined with loratadine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when nicardipine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with furosemide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with ethotoin.


The risk or severity of adverse effects can be increased when amisulpride is combined with efavirenz.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with prilocaine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when estazolam is combined with triprolidine.


The risk or severity of adverse effects can be increased when pergolide is combined with Zucapsaicin.


The risk or severity of adverse effects can be increased when cilazapril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when estazolam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Conivaptan is combined with benazepril.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when enflurane is combined with Melatonin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with nabumetone.


The risk or severity of adverse effects can be increased when meperidine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with procarbazine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with tenoxicam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when clonidine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when oxprenolol is combined with maprotiline.


The risk or severity of adverse effects can be increased when Mometasone is combined with donepezil.


The risk or severity of adverse effects can be increased when nicergoline is combined with Telithromycin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with ritodrine.


The risk or severity of adverse effects can be increased when butorphanol is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when tirofiban is combined with salicylic acid.


The risk or severity of adverse effects can be increased when equilin is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with butorphanol.


The risk or severity of adverse effects can be increased when apomorphine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with dantrolene.


The risk or severity of adverse effects can be increased when brotizolam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ketorolac is combined with medrysone.


The risk or severity of adverse effects can be increased when benazepril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when brotizolam is combined with triprolidine.


The risk or severity of adverse effects can be increased when tizanidine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with sotalol.


The risk or severity of adverse effects can be increased when maprotiline is combined with dantrolene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with tretinoin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with brimonidine.


The risk or severity of adverse effects can be increased when quazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with prilocaine.


The risk or severity of adverse effects can be increased when benzphetamine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when leflunomide is combined with Halobetasol.


The risk or severity of adverse effects can be increased when amoxapine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when amantadine is combined with bupropion.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with haloperidol.


The risk or severity of adverse effects can be increased when Torasemide is combined with timolol.


The risk or severity of adverse effects can be increased when flurazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when leflunomide is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with amisulpride.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when metolazone is combined with deslanoside.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with benazepril.


The risk or severity of adverse effects can be increased when captopril is combined with nadolol.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Phenelzine.


The risk or severity of adverse effects can be increased when buspirone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when buspirone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when salicylamide is combined with equilin.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with orphenadrine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with meperidine.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when halothane is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with primidone.


The risk or severity of adverse effects can be increased when labetalol is combined with quetiapine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with dicyclomine.


The risk or severity of adverse effects can be increased when dopamine is combined with acebutolol.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with benzocaine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Desloratadine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Posaconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with betamethasone.


The risk or severity of adverse effects can be increased when clomipramine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when clomipramine is combined with tolazoline.


The risk or severity of adverse effects can be increased when Micafungin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Micafungin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Micafungin is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Micafungin is combined with Benidipine.


The risk or severity of adverse effects can be increased when Micafungin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with pimozide.


The risk or severity of adverse effects can be increased when fenoprofen is combined with estrone.


The risk or severity of adverse effects can be increased when barnidipine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with benazepril.


The risk or severity of adverse effects can be increased when brotizolam is combined with venlafaxine.


The risk or severity of adverse effects can be increased when brotizolam is combined with clemastine.


The risk or severity of adverse effects can be increased when ipratropium is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when lorazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with enflurane.


The risk or severity of adverse effects can be increased when Torasemide is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when butabarbital is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with etizolam.


The risk or severity of adverse effects can be increased when butabarbital is combined with oxazepam.


The risk or severity of adverse effects can be increased when perphenazine is combined with thiothixene.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when butabarbital is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when perphenazine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when propofol is combined with lithium ion.


The risk or severity of adverse effects can be increased when moclobemide is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with penbutolol.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when timolol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Remoxipride.


The risk or severity of adverse effects can be increased when pentobarbital is combined with loxapine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when oxazepam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Torasemide is combined with labetalol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with spironolactone.


The risk or severity of adverse effects can be increased when buspirone is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Torasemide is combined with doxazosin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Torasemide is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with mecamylamine.


The risk or severity of adverse effects can be increased when meperidine is combined with levodopa.


The risk or severity of adverse effects can be increased when meperidine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Eprosartan is combined with bumetanide.


The risk or severity of adverse effects can be increased when Aclidinium is combined with oxycodone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when meperidine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when meperidine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when baclofen is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when estazolam is combined with amisulpride.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when oxycodone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Halazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with aspirin.


The risk or severity of adverse effects can be increased when estazolam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when pentazocine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ketorolac is combined with niflumic acid.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfamethazine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfamerazine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Fosphenytoin is combined with lithium ion.


The risk or severity of adverse effects can be increased when moclobemide is combined with Cariprazine.


The risk or severity of adverse effects can be increased when methylene blue is combined with bupropion.


The risk or severity of adverse effects can be increased when pimozide is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when etodolac is combined with Mometasone.


The risk or severity of adverse effects can be increased when Tramadol is combined with loxapine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with terazosin.


The risk or severity of adverse effects can be increased when Tramadol is combined with alprazolam.


The risk or severity of adverse effects can be increased when Tramadol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with procarbazine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ibuprofen.


The risk or severity of adverse effects can be increased when rizatriptan is combined with amisulpride.


The risk or severity of adverse effects can be increased when Toloxatone is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Asenapine.


The risk or severity of adverse effects can be increased when lithium ion is combined with Retigabine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when paroxetine is combined with tiapride.


The risk or severity of adverse effects can be increased when Tavaborole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when betaxolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when ethopropazine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when phenobarbital is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when ethopropazine is combined with tropicamide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Almotriptan is combined with risperidone.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Tramadol.


The risk or severity of adverse effects can be increased when butabarbital is combined with vigabatrin.


The risk or severity of adverse effects can be increased when butabarbital is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Artemether is combined with flunarizine.


The risk or severity of adverse effects can be increased when trimipramine is combined with doxepin.


The risk or severity of adverse effects can be increased when chlortetracycline is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when butabarbital is combined with benzocaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when diclofenac is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Efonidipine is combined with imipramine.


The risk or severity of adverse effects can be increased when dyclonine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with efavirenz.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with imipramine.


The risk or severity of adverse effects can be increased when meprobamate is combined with dyclonine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ramipril.


The risk or severity of adverse effects can be increased when methadone is combined with desipramine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with buprenorphine.


The risk or severity of adverse effects can be increased when amifostine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with enoxacin.


The risk or severity of adverse effects can be increased when MELPERONE is combined with tiapride.


The risk or severity of adverse effects can be increased when triflupromazine is combined with HEROIN.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with citric acid.


The risk or severity of adverse effects can be increased when Butoconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when valsartan is combined with metolazone.


The risk or severity of adverse effects can be increased when valsartan is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when indomethacin is combined with difluprednate.


The risk or severity of adverse effects can be increased when chlormezanone is combined with phenytoin.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Nepafenac.


The risk or severity of adverse effects can be increased when atenolol is combined with diltiazem.


The risk or severity of adverse effects can be increased when quazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when phentolamine is combined with quetiapine.


The risk or severity of adverse effects can be increased when topiramate is combined with metformin.


The risk or severity of adverse effects can be increased when fluocinonide is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with dantrolene.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with protriptyline.


The risk or severity of adverse effects can be increased when nitrazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Agomelatine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when ipratropium is combined with Propiverine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with Olsalazine.


The risk or severity of adverse effects can be increased when meperidine is combined with Alvimopan.


The risk or severity of adverse effects can be increased when metoclopramide is combined with periciazine.


The risk or severity of adverse effects can be increased when tretinoin is combined with tizanidine.


The risk or severity of adverse effects can be increased when tretinoin is combined with furosemide.


The risk or severity of adverse effects can be increased when carprofen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when tretinoin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when pergolide is combined with Linagliptin.


The risk or severity of adverse effects can be increased when zopiclone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Pirlindole is combined with droxidopa.


The risk or severity of adverse effects can be increased when pergolide is combined with clomiphene.


The risk or severity of adverse effects can be increased when zopiclone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when promazine is combined with clidinium.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with oxycodone.


The risk or severity of adverse effects can be increased when sulpiride is combined with trazodone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Clobetasone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Delorazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when furosemide is combined with acebutolol.


The risk or severity of adverse effects can be increased when butabarbital is combined with alprazolam.


The risk or severity of adverse effects can be increased when furosemide is combined with captopril.


The risk or severity of adverse effects can be increased when butabarbital is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when tretinoin is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when tretinoin is combined with metolazone.


The risk or severity of adverse effects can be increased when nisoldipine is combined with captopril.


The risk or severity of adverse effects can be increased when propoxyphene is combined with felbamate.


The risk or severity of adverse effects can be increased when pargyline is combined with lithium ion.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Arbekacin.


The risk or severity of adverse effects can be increased when midazolam is combined with trazodone.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with quinapril.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when baclofen is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Tiotropium is combined with levorphanol.


The risk or severity of adverse effects can be increased when Pinaverium is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when triflupromazine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with promazine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with nalbuphine.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with Demecarium.


The risk or severity of adverse effects can be increased when linezolid is combined with Pipamperone.


The risk or severity of adverse effects can be increased when fosinopril is combined with lisinopril.


The risk or severity of adverse effects can be increased when Olsalazine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when nimesulide is combined with Mometasone.


The risk or severity of adverse effects can be increased when Etidocaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when nicergoline is combined with tofisopam.


The risk or severity of adverse effects can be increased when Clofarabine is combined with benazepril.


The risk or severity of adverse effects can be increased when Etidocaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Lurasidone.


The risk or severity of adverse effects can be increased when nicergoline is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when olanzapine is combined with ketamine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with alclometasone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with modafinil.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with formestane.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when epirizole is combined with difluprednate.


The risk or severity of adverse effects can be increased when epirizole is combined with halcinonide.


The risk or severity of adverse effects can be increased when fusidic acid is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when docetaxel is combined with IDARUBICIN.


The risk or severity of adverse effects can be increased when Fospropofol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when butalbital is combined with Pizotifen.


The risk or severity of adverse effects can be increased when docetaxel is combined with CABAZITAXEL.


The risk or severity of adverse effects can be increased when methyldopa is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Milnacipran.


The risk or severity of adverse effects can be increased when docetaxel is combined with podophyllotoxin.


The risk or severity of adverse effects can be increased when methyldopa is combined with Metipranolol.


The risk or severity of adverse effects can be increased when rapamycin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with betamethasone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with HEROIN.


The risk or severity of adverse effects can be increased when procarbazine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Melatonin is combined with flunarizine.


The risk or severity of adverse effects can be increased when methadone is combined with theobromine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Melatonin is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Articaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with irbesartan.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when dapsone is combined with Isometheptene.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with felodipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with furazolidone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when nitrazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when ondansetron is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when venlafaxine is combined with meperidine.


The risk or severity of adverse effects can be increased when thalidomide is combined with ramipril.


The risk or severity of adverse effects can be increased when loratadine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Eslicarbazepine acetate is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when antipyrine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with sulpiride.


The risk or severity of adverse effects can be increased when Olopatadine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Pirlindole is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with amobarbital.


The risk or severity of adverse effects can be increased when captopril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Halazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when sulpiride is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when ondansetron is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when procaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with felbamate.


The risk or severity of adverse effects can be increased when Levalbuterol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when buprenorphine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when bromocriptine is combined with raloxifene.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Nabilone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with brimonidine.


The risk or severity of adverse effects can be increased when ethotoin is combined with primidone.


The risk or severity of adverse effects can be increased when Nabilone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when propoxyphene is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when budesonide is combined with edrophonium.


The risk or severity of adverse effects can be increased when reserpine is combined with quetiapine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with pramipexole.


The risk or severity of adverse effects can be increased when chloroquine is combined with Apremilast.


The risk or severity of adverse effects can be increased when diflunisal is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Panobinostat.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with clemastine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when diazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when midazolam is combined with estazolam.


The risk or severity of adverse effects can be increased when reserpine is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when midazolam is combined with dantrolene.


The risk or severity of adverse effects can be increased when alprazolam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when bezafibrate is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when buspirone is combined with clonazepam.


The risk or severity of adverse effects can be increased when biperiden is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Etidocaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with carvedilol.


The risk or severity of adverse effects can be increased when apraclonidine is combined with methyldopa.


The risk or severity of adverse effects can be increased when Pirlindole is combined with mirtazapine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when nitrendipine is combined with reserpine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Rotigotine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when butalbital is combined with dantrolene.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when losartan is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when lorazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when losartan is combined with terazosin.


The risk or severity of adverse effects can be increased when methysergide is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Amrinone.


The risk or severity of adverse effects can be increased when carprofen is combined with epirizole.


The risk or severity of adverse effects can be increased when oxiconazole is combined with lovastatin.


The risk or severity of adverse effects can be increased when ethanol is combined with furazolidone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when sotalol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when temazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Zucapsaicin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Eplerenone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with methazolamide.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with benazepril.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when levorphanol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when pentazocine is combined with prazepam.


The risk or severity of adverse effects can be increased when furosemide is combined with ribostamycin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with fosinopril.


The risk or severity of adverse effects can be increased when Clevidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with terazosin.


The risk or severity of adverse effects can be increased when mecamylamine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when deferoxamine is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with metolazone.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with diflunisal.


The risk or severity of adverse effects can be increased when meperidine is combined with polythiazide.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with donepezil.


The risk or severity of adverse effects can be increased when tiagabine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when phenylephrine is combined with benzphetamine.


The risk or severity of adverse effects can be increased when metolazone is combined with Clevidipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with quazepam.


The risk or severity of adverse effects can be increased when Nabilone is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Calcium acetate is combined with Doxercalciferol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with doxepin.


The risk or severity of adverse effects can be increased when dexamethasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with fenbufen.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with morphine.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with methyldopa.


The risk or severity of adverse effects can be increased when glutethimide is combined with Etidocaine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Icatibant.


The risk or severity of adverse effects can be increased when LISURIDE is combined with cilostazol.


The risk or severity of adverse effects can be increased when digoxin is combined with adenosine.


The risk or severity of adverse effects can be increased when Clobetasone is combined with donepezil.


The risk or severity of adverse effects can be increased when oxymorphone is combined with trimipramine.


The risk or severity of adverse effects can be increased when nabumetone is combined with alclofenac.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when isoflurane is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when minoxidil is combined with Nebivolol.


The risk or severity of adverse effects can be increased when budesonide is combined with cinoxacin.


The risk or severity of adverse effects can be increased when cilazapril is combined with penbutolol.


The risk or severity of adverse effects can be increased when isoflurane is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with bumetanide.


The risk or severity of adverse effects can be increased when olanzapine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with eperisone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Salmeterol.


The risk or severity of adverse effects can be increased when clonazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when rasagiline is combined with tizanidine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with maprotiline.


The risk or severity of adverse effects can be increased when rasagiline is combined with furosemide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with mesoridazine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Pregabalin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with maprotiline.


The risk or severity of adverse effects can be increased when ILOPROST is combined with sotalol.


The risk or severity of adverse effects can be increased when Benidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when thiothixene is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when HEROIN is combined with Conivaptan.


The risk or severity of adverse effects can be increased when metoclopramide is combined with citalopram.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Nabilone.


The risk or severity of adverse effects can be increased when nitrendipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when gabapentin is combined with Halazepam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with antipyrine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Voriconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when rapamycin is combined with felodipine.


The risk or severity of adverse effects can be increased when dorzolamide is combined with primidone.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when loxapine is combined with Articaine.


The risk or severity of adverse effects can be increased when thalidomide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when trazodone is combined with Retigabine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with clomiphene.


The risk or severity of adverse effects can be increased when minoxidil is combined with felodipine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when trazodone is combined with cabergoline.


The risk or severity of adverse effects can be increased when aspirin is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with nefazodone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when trazodone is combined with butalbital.


The risk or severity of adverse effects can be increased when lorazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with methscopolamine.


The risk or severity of adverse effects can be increased when citalopram is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Netupitant is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when suprofen is combined with alclometasone.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with nylidrin.


The risk or severity of adverse effects can be increased when pramipexole is combined with Torasemide.


The risk or severity of adverse effects can be increased when codeine is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Salsalate.


The risk or severity of adverse effects can be increased when pentazocine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when buspirone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when flurazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with alclometasone.


The risk or severity of adverse effects can be increased when enalapril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when apomorphine is combined with isoflurane.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when methscopolamine is combined with topiramate.


The risk or severity of adverse effects can be increased when oxycodone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when enalapril is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when thiothixene is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with topiramate.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when amifostine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with amoxapine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with benazepril.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when salicylic acid is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Efonidipine is combined with halothane.


The risk or severity of adverse effects can be increased when docetaxel is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Nilotinib.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Ephedrine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when loxapine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with zotepine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with MELPERONE.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with DESONIDE.


The risk or severity of adverse effects can be increased when epinastine is combined with Olsalazine.


The risk or severity of adverse effects can be increased when warfarin is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Nabilone is combined with captopril.


The risk or severity of adverse effects can be increased when buspirone is combined with prilocaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when morniflumate is combined with Nepafenac.


The risk or severity of adverse effects can be increased when Spirapril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Asenapine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Etomidate.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with topiramate.


The risk or severity of adverse effects can be increased when loxapine is combined with etizolam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with bupivacaine.


The risk or severity of adverse effects can be increased when oxycodone is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with acemetacin.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with nalbuphine.


The risk or severity of adverse effects can be increased when methscopolamine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when isoflurane is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when oxycodone is combined with clorazepate.


The risk or severity of adverse effects can be increased when procyclidine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Ramelteon.


The risk or severity of adverse effects can be increased when dyclonine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Butethal is combined with ethosuximide.


The risk or severity of adverse effects can be increased when methylene blue is combined with Isometheptene.


The risk or severity of adverse effects can be increased when Nabilone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with maprotiline.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with acemetacin.


The risk or severity of adverse effects can be increased when ketamine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when promazine is combined with estazolam.


The risk or severity of adverse effects can be increased when zopiclone is combined with brotizolam.


The risk or severity of adverse effects can be increased when mepivacaine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when propofol is combined with terazosin.


The risk or severity of adverse effects can be increased when triazolam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when triazolam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when clozapine is combined with brotizolam.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with venlafaxine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when doxazosin is combined with nicardipine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when apomorphine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when imipramine is combined with hydralazine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Nabilone is combined with Clevidipine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with ramipril.


The risk or severity of adverse effects can be increased when flunisolide is combined with malathion.


The risk or severity of adverse effects can be increased when cilnidipine is combined with pravastatin.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Lacidipine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with valsartan.


The risk or severity of adverse effects can be increased when flunisolide is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with methadone.


The risk or severity of adverse effects can be increased when tropicamide is combined with topiramate.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with terazosin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with scopolamine.


The risk or severity of adverse effects can be increased when Normethadone is combined with trimipramine.


The risk or severity of adverse effects can be increased when tolazoline is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Articaine.


The risk or severity of adverse effects can be increased when diltiazem is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Riociguat.


The risk or severity of adverse effects can be increased when Agomelatine is combined with levodopa.


The risk or severity of adverse effects can be increased when ethotoin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with dantrolene.


The risk or severity of adverse effects can be increased when prilocaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Conivaptan is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when amisulpride is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with tetracaine.


The risk or severity of adverse effects can be increased when protriptyline is combined with metaproterenol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when olanzapine is combined with dibucaine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with tetracaine.


The risk or severity of adverse effects can be increased when methoxamine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when mepivacaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Naftifine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when maprotiline is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when nifedipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when spironolactone is combined with nifedipine.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with cilazapril.


The risk or severity of adverse effects can be increased when spironolactone is combined with papaverine.


The risk or severity of adverse effects can be increased when morphine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when norepinephrine is combined with benzphetamine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when norepinephrine is combined with ritodrine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with amcinonide.


The risk or severity of adverse effects can be increased when Halazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with zotepine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Droxicam.


The risk or severity of adverse effects can be increased when carbamazepine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when tretinoin is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Belinostat is combined with clozapine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with flunarizine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when labetalol is combined with indapamide.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when ropinirole is combined with losartan.


The risk or severity of adverse effects can be increased when glutethimide is combined with scopolamine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when tizanidine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with HEROIN.


The risk or severity of adverse effects can be increased when Agomelatine is combined with baclofen.


The risk or severity of adverse effects can be increased when salicylamide is combined with Clobetasone.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with midodrine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when propantheline is combined with Desloratadine.


The risk or severity of adverse effects can be increased when amisulpride is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when clotrimazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Ramelteon.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Metipranolol.


The risk or severity of adverse effects can be increased when apraclonidine is combined with captopril.


The risk or severity of adverse effects can be increased when zotepine is combined with meclizine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when apraclonidine is combined with acebutolol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with irbesartan.


The risk or severity of adverse effects can be increased when Trospium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when clozapine is combined with minoxidil.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with acemetacin.


The risk or severity of adverse effects can be increased when codeine is combined with quazepam.


The risk or severity of adverse effects can be increased when codeine is combined with prazepam.


The risk or severity of adverse effects can be increased when metolazone is combined with dipyridamole.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when codeine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when triprolidine is combined with loratadine.


The risk or severity of adverse effects can be increased when codeine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when oxazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when medrysone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when gabapentin is combined with etizolam.


The risk or severity of adverse effects can be increased when indapamide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when valsartan is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Miltefosine is combined with flunarizine.


The risk or severity of adverse effects can be increased when salicylamide is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when triazolam is combined with quazepam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with maprotiline.


The risk or severity of adverse effects can be increased when sevoflurane is combined with salicylic acid.


The risk or severity of adverse effects can be increased when sevoflurane is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Tadalafil is combined with Vardenafil.


The risk or severity of adverse effects can be increased when sotalol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Droxicam is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with doxepin.


The risk or severity of adverse effects can be increased when tolbutamide is combined with ethanol.


The risk or severity of adverse effects can be increased when lidocaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with thioridazine.


The risk or severity of adverse effects can be increased when Icatibant is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with dyclonine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with sulpiride.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with olanzapine.


The risk or severity of adverse effects can be increased when pergolide is combined with acetaminophen.


The risk or severity of adverse effects can be increased when pergolide is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when ipratropium is combined with topiramate.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when betaxolol is combined with methyldopa.


The risk or severity of adverse effects can be increased when ketoprofen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when captopril is combined with penbutolol.


The risk or severity of adverse effects can be increased when etizolam is combined with clonidine.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with memantine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Apremilast is combined with salicylamide.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with diflorasone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with dantrolene.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when codeine is combined with baclofen.


The risk or severity of adverse effects can be increased when morniflumate is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when clomipramine is combined with spironolactone.


The risk or severity of adverse effects can be increased when codeine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Nabilone is combined with triamterene.


The risk or severity of adverse effects can be increased when Almotriptan is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when meprobamate is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when isoflurane is combined with ramipril.


The risk or severity of adverse effects can be increased when triazolam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when isoflurane is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when isoflurane is combined with valsartan.


The risk or severity of adverse effects can be increased when Sacubitril is combined with metolazone.


The risk or severity of adverse effects can be increased when Salsalate is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when ramipril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Sacubitril is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ramipril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when bumetanide is combined with kanamycin.


The risk or severity of adverse effects can be increased when bumetanide is combined with IDARUBICIN.


The risk or severity of adverse effects can be increased when hexetidine is combined with nimesulide.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Butethal.


The risk or severity of adverse effects can be increased when Butoconazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with lithium ion.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with cabergoline.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with benzocaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when bromazepam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when cilazapril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Riociguat.


The risk or severity of adverse effects can be increased when butabarbital is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when fluoxetine is combined with imipramine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with difluprednate.


The risk or severity of adverse effects can be increased when floctafenine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with prilocaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with isoflurane.


The risk or severity of adverse effects can be increased when clorazepate is combined with ethotoin.


The risk or severity of adverse effects can be increased when prazosin is combined with mecamylamine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with zonisamide.


The risk or severity of adverse effects can be increased when Naftifine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with lisinopril.


The risk or severity of adverse effects can be increased when furosemide is combined with nadolol.


The risk or severity of adverse effects can be increased when mepivacaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when bromazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when zidovudine is combined with clozapine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when estazolam is combined with Fospropofol.